Shao Jing Tong
Finanzdirektor/CFO bei REMEGEN CO., LTD.
Profil
Derzeit hat Shaojing Tong die Position des Chief Financial Officer bei InnoCare Pharma Ltd. inne. Herr Tong ist auch im Vorstand der YishengBio Co., Ltd. tätig. Herr Tong war zuvor Director-Global Research bei Bank of America Merrill Lynch (New York), Research Analyst bei Mehta Partners LLC, Executive Director-Investment Banking Research bei UBS (China) Ltd, Research Analyst bei Merrill Lynch Far East Ltd. und Analyst bei UBS Securities (Asia) Ltd. Shaojing Tong erwarb einen MBA an der New York University, einen Graduate-Abschluss an der University of Pittsburgh und einen Bachelor-Abschluss an der University of Science & Technology of China.
Aktive Positionen von Shao Jing Tong
Unternehmen | Position | Beginn |
---|---|---|
REMEGEN CO., LTD. | Finanzdirektor/CFO | 28.09.2023 |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Shao Jing Tong
Unternehmen | Position | Ende |
---|---|---|
LAKESHORE BIOPHARMA CO., LTD | Direktor/Vorstandsmitglied | 29.02.2024 |
INNOCARE PHARMA LIMITED | Finanzdirektor/CFO | 31.12.2022 |
UBS Securities (Asia) Ltd.
UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Analyst-Equity | 31.05.2019 |
UBS (China) Ltd.
UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The company is based in Beijing, China. | Corporate Officer/Principal | 01.05.2019 |
Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | 01.05.2013 |
Ausbildung von Shao Jing Tong
New York University | Masters Business Admin |
University of Pittsburgh | Graduate Degree |
University of Science & Technology of China | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
INNOCARE PHARMA LIMITED | Health Technology |
LAKESHORE BIOPHARMA CO., LTD | Health Technology |
REMEGEN CO., LTD. | Health Technology |
Private Unternehmen | 6 |
---|---|
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Founded in 1980, Mehta Partners LLC is a research firm located in New York City. The universe Mehta monitors includes biopharmaceutical companies in the U.S., Europe, Japan and emerging markets including Brazil, China, Eastern Europe and India. They cover 400 companies that are classified by geography and maturity. | Finance |
Merrill Lynch Far East Ltd.
Merrill Lynch Far East Ltd. Investment Banks/BrokersFinance Merrill Lynch Far East Ltd. is the stockbroking subsidiary of Merrill Lynch HK Services Ltd., ultimately owned by Bank of America Corp. (NYSE: BAC) in the US. Headquartered in Hong Kong, the firm was founded in 2003 and offers a broad range of brokerage services to institutional investors. | Finance |
UBS Securities (Asia) Ltd.
UBS Securities (Asia) Ltd. Investment Banks/BrokersFinance UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals. | Finance |
Bank of America Merrill Lynch (New York) | |
UBS (China) Ltd.
UBS (China) Ltd. Major BanksFinance Part of UBS Group AG, UBS (China) Ltd. provides retail and commercial banking services. The company is based in Beijing, China. | Finance |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |